Immix Biopharma, Inc.
NASDAQ:IMMX
2.09 (USD) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 17.682 | 17.51 | 13.437 | 17.644 | 0.391 | 0.734 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 17.682 | 17.51 | 13.437 | 17.644 | 0.391 | 0.734 |
| Net Receivables
| 0 | 1.172 | 0.256 | 0.026 | 0.127 | 0.176 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 0.032 | 1.106 | 1.205 | 0.516 | 0.014 | 0.024 |
| Total Current Assets
| 20.198 | 19.788 | 14.898 | 18.186 | 0.532 | 0.933 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 2.73 | 0.05 | 0.004 | 0.006 | 0.007 | 0.01 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.02 | 0.087 | 0.007 | -0 | -0 | -0 |
| Total Non-Current Assets
| 2.75 | 0.137 | 0.01 | 0.006 | 0.007 | 0.01 |
| Total Assets
| 22.948 | 19.925 | 14.908 | 18.192 | 0.54 | 0.943 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 5.388 | 1.433 | 0.143 | 0.143 | 0.252 | 0.248 |
| Short Term Debt
| 0.065 | 0 | 0 | 0.05 | 4.1 | 4.1 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0.343 | 0 |
| Other Current Liabilities
| 3.233 | 2.289 | 1.13 | 0.009 | 0.918 | 0.242 |
| Total Current Liabilities
| 8.687 | 3.722 | 1.273 | 0.202 | 5.27 | 4.589 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0.475 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 1.01 | 0 | 0.475 | 0 | 0 | 0 |
| Total Liabilities
| 9.697 | 3.722 | 1.748 | 0.202 | 5.27 | 4.589 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.003 | 0.002 | 0.001 | 0.001 | 0 | 0 |
| Retained Earnings
| -75.025 | -53.411 | -37.985 | -29.756 | -5.372 | -4.224 |
| Accumulated Other Comprehensive Income/Loss
| -0.001 | 0.135 | 0.087 | 0.125 | 0.132 | 0.068 |
| Other Total Stockholders Equity
| 88.274 | 69.68 | 51.057 | 47.619 | 0.509 | 0.509 |
| Total Shareholders Equity
| 13.251 | 16.405 | 13.16 | 17.99 | -4.731 | -3.646 |
| Total Equity
| 13.251 | 16.203 | 13.16 | 17.99 | -4.731 | -3.646 |
| Total Liabilities & Shareholders Equity
| 22.948 | 19.925 | 14.908 | 18.192 | 0.54 | 0.943 |